News

Need something for here

Current News

Federal Judge Sides with Schulman Bhattacharya in Ongoing False Advertising Dispute, Holds Pharma Companies in Contempt for “Blatant” Violations of Permanent Injunction

In a decision issued yesterday, Judge Theodore D. Chuang of the United States District Court for the District of Maryland ruled in favor of Schulman Bhattacharya’s client, ExeGi Pharma, LLC, holding its competitors Alfasigma USA, Inc. and VSL Pharmaceuticals, Inc. in contempt of the Permanent Injunction entered last year aimed at halting false advertising of the probiotic medical food VSL#3. This is the latest round in the ongoing legal battle over the highly successful, proprietary probiotic formulation invented by Schulman... read more →

Maryland Court Enters Preliminary Injunction Protecting Interest of Schulman Bhattacharya Client in $480 Million Asset Sale

Schulman Bhattacharya, on behalf of its client, Sachs Capital, LLC, filed a Complaint and motion for a temporary restraining order and preliminary injunction in the Circuit Court for Montgomery County, Maryland, seeking to protect Sachs Capital's interests in the proceeds of a $480 million sale of a major national petroleum company. Sachs Capital, and its related entities, invested more than $31 million in the petroleum company and is set to receive a preferred return on its investment as the sale... read more →

D.C. Federal Court Upholds Discrimination and Retaliation Claims Brought By Schulman Bhattacharya Against Howard University

Schulman Bhattacharya, on behalf of its client, Dr. Mohsen Mosleh, filed a complaint against Howard University in the United States District Court for the District of Columbia for its violations of the D.C. Human Rights Act.  Dr. Mosleh, a tenured professor at Howard University of Iranian descent, asserts claims against the university for its long-standing discrimination against him on the basis of race and national origin and various acts of retaliation against him.  On February 27, 2020, Judge Carl J. Nichols... read more →

Schulman Bhattacharya’s Bio-Tech Litigation Practice Secures Another Victory in Federal Court

Schulman Bhattacharya’s bio-tech litigation practice, which helped clients win more than $91 million dollars in trial verdicts over the past three years, has secured another significant victory.  This time, Schulman Bhattacharya represented a defendant, renowned pharmaceutical executive Gregg Lapointe, in a case filed in the United States District Court for the District of Maryland.  The plaintiff in Washington County Board of Education v. Mallinckrodt Ard Inc., et al., sought to buttress its case by adding Mr. Lapointe as a defendant, alleging... read more →

Schulman Bhattacharya Successfully Defends Famed Investment Banker; Quashes Series of Subpoenas Aimed at Obtaining his Personal, Private Information

A famed, foreign investment banker retained Schulman Bhattacharya after a series of third-party providers, including Google, Microsoft, and LinkedIn, received subpoenas demanding production of the bankers’ emails, browsing history, payment details, and other invasive personal and business information.  The subpoenas were issued as part of far-reaching discovery in a case currently pending in the United States District Court for the Southern District of New York and sought to drag the banker into the heart of that case.  Schulman Bhattacharya faced... read more →

Schulman Bhattacharya Engaged to Represent Hormuud Telecom in U.S. Defamation Cases and United Nations Disputes

Hormuud Telecom, the largest telecom company in Somalia and the country’s largest employer and taxpayer, has engaged Schulman Bhattacharya to defend its interests in contentious disputes with various U.S.-based media organizations and the United Nations.  Commenting on the engagement, Jeremy W. Schulman, the Firm’s Managing Member, stated:  “We are pleased to be representing one of the most vital companies in East Africa, helping to protect its legal rights and interests and clearing its name of scurrilous allegations intended to hamper... read more →

Schulman Bhattacharya Continues Rapid Growth—Famed Corporate Lawyer and Executive Joins the Firm, Along with Experienced Commercial Litigator

Schulman Bhattacharya, LLC is proud to announce the hiring of two new attorneys who will be resident in the Firm’s Washington-area headquarters office.  Jamie Karson joins the firm as Of Counsel.  Jake Schaller arrives as an Associate. Jamie Karson is the former Chief Executive Officer and Chairman of the Board of Steve Madden Ltd. (NASDAQ: “SHOO”), one of the most iconic footwear brands in the world.  During his tenure at the helm of Steve Madden, the company’s market capitalization reached... read more →

Schulman Bhattacharya Files Sixteen Count Federal Class Action Lawsuit Against Distributors of VSL#3 Probiotic Product–Named Plaintiff-Victims from Massachusetts, California, Texas, New Jersey, Michigan, Illinois, Washington, Florida, and Idaho

On July 23, 2019, Schulman Bhattacharya commenced a class action lawsuit against the U.S. licensor (VSL Pharmaceuticals, Inc.) and distributors (Alfasigma USA, Inc. and Leadiant Biosciences, Inc.) of the VSL#3 probiotic product.  Our complaint, which was filed in the United States District Court for the District of Maryland, asserts sixteen cause of action on behalf of a nationwide class of victims who purchased VSL#3 since June 2016, as well as consumers in subclasses in Massachusetts, California, Texas, New Jersey, Michigan,... read more →

Federal Judge Upholds $18 Million Jury Verdict in Favor of Schulman Bhattacharya’s Clients, Enters Broad Permanent Injunction to Block Further False Advertising of the VSL#3 Product

In 54 pages of rulings issued this past Friday, June 21, 2019, Judge Theodore D. Chuang of the United States District Court for the District of Maryland found decisively in favor of Schulman Bhattacharya’s clients—Professor Claudio De Simone and ExeGi Pharma, LLC—upholding our $18 million jury verdict from November 2018 and entering a permanent injunction against the current and former distributors of VSL#3, halting their false advertising of the product.  The rulings conclude over four years of litigation in which... read more →

Schulman Bhattacharya Prevails After Filing California Federal Court Action—Major Internet Commerce Companies Yield to Demand to Block On-Line Sales Transactions for VSL#3 Product

In Schulman Bhattacharya’s ongoing battle over the VSL#3 probiotic product, the Firm successfully resolved a contentious dispute between its client, ExeGi Pharma, LLC, and a group of companies in California that were facilitating the processing of online sales transactions for VSL#3.  The e-commerce companies in question are Nexternal Solutions, Inc., True Commerce, Inc., and HighJump Software, Inc.  Last November, the Firm prevailed before a jury in Maryland federal court and then obtained a judgment holding that the VSL#3 product was... read more →